Bio-Techne (TECH) Cash from Investing Activities Growth (1y) (2010 - 2026)
Bio-Techne (TECH) Cash from Investing Activities Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 62.68% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -674.01% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -166.24% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Bio-Techne | 11.20 Bn | 10.99 Bn | 208.29 Mn | 34.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.44% |
| Dec 31, 2025 | -17.67% |
| Sep 30, 2025 | 102.79% |
| Jun 30, 2025 | 104.61% |
| Mar 31, 2025 | 46.03% |
| Dec 31, 2024 | 78.74% |
| Sep 30, 2024 | 85.93% |
| Jun 30, 2024 | -85.20% |
| Mar 31, 2024 | 93.18% |
| Dec 31, 2023 | -21,616.51% |
| Sep 30, 2023 | -682.76% |
| Jun 30, 2023 | 74.39% |
| Mar 31, 2023 | -569.84% |
| Dec 31, 2022 | 99.69% |
| Sep 30, 2022 | -176.52% |
| Jun 30, 2022 | 91.82% |
| Mar 31, 2022 | -28,001.55% |
| Dec 31, 2021 | -308.74% |
| Sep 30, 2021 | 12.51% |
| Jun 30, 2021 | -2,066.55% |